Abstract
We report a unique case of periocular nonnecrobiotic necrobiotic xanthogranuloma in a 52-year-old white woman with Sjögren syndrome who was subsequently found to have an immunoglobulin G paraproteinemia and coexisting small lymphocytic lymphoma. Therapy with fludarabine, cytoxan, and rituximab (FCR) resulted in a dramatic resolution of her sicca symptoms and periocular xanthogranulomas. This case further illustrates the association of hematolymphoid disorders with cutaneous xanthogranulomatous disease and the importance of additional appropriate laboratory and radiologic investigation for the accurate diagnosis of an underlying malignancy.
MeSH terms
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use
-
Antineoplastic Agents / therapeutic use
-
Biopsy
-
Cyclophosphamide / therapeutic use
-
Drug Therapy, Combination
-
Eyelids / pathology
-
Female
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Leukemia, Lymphocytic, Chronic, B-Cell / complications*
-
Leukemia, Lymphocytic, Chronic, B-Cell / immunology
-
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
-
Middle Aged
-
Necrobiotic Xanthogranuloma / drug therapy
-
Necrobiotic Xanthogranuloma / etiology*
-
Necrobiotic Xanthogranuloma / immunology
-
Necrobiotic Xanthogranuloma / pathology
-
Paraproteinemias / complications*
-
Paraproteinemias / drug therapy
-
Paraproteinemias / immunology
-
Paraproteinemias / pathology
-
Rituximab
-
Sjogren's Syndrome / complications*
-
Sjogren's Syndrome / drug therapy
-
Sjogren's Syndrome / immunology
-
Sjogren's Syndrome / pathology
-
Treatment Outcome
-
Vidarabine / analogs & derivatives
-
Vidarabine / therapeutic use
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Agents
-
Immunosuppressive Agents
-
Rituximab
-
Cyclophosphamide
-
Vidarabine
-
fludarabine